Phase II Study of the Hyper - CVAD Regimen in Combination with Ofatumumab as Frontline Therapy for patients with CD-20 positive Acute Lymphoblastic Leukemia
If you are reading and signing this form on behalf of a potential participant, please note: Any time the words "you," "your," "I," or "me" appear, it is meant to apply to the potential participant. The goal of this clinical research study is to learn if ofatumumab combined with standard chemotherapy can help to control acute lymphoblastic leukemia (ALL). The safety of these drug combinations will also be studied.
Treatment Location: N/A
IRB Review and Approval Date: 07/12/2011
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
For general questions about clinical trials: